Comment on OMB-2026-0034-0001

Summary: The American Brain Tumor Association opposes the proposed OMB Regulation for Federal Financial Assistance, arguing it would undermine scientific peer review by introducing political oversight and allow for the arbitrary termination of research grants. The organization expresses concern that these changes would disrupt long-term cancer research, endanger patients in clinical trials, and impose significant compliance costs on institutions.